Filing Details

Accession Number:
0001415889-22-009915
Form Type:
4/A
Zero Holdings:
No
Publication Time:
2022-09-23 17:35:48
Reporting Period:
2022-09-21
Accepted Time:
2022-09-23 17:35:48
Original Submission Date:
2022-09-22
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1750284 Olema Pharmaceuticals Inc. OLMA Pharmaceutical Preparations (2834) 300409740
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1831218 Sean Bohen C/O Olema Pharmaceuticals, Inc.
512 2Nd Street, 4Th Floor
San Francisco CA 94107
President And Ceo No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2022-09-21 20,000 $0.00 74,279 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Footnotes
  1. This amendment is being filed solely to correct the transaction code in column 3 of Table I from code "A" to code "P".
  2. The weighted average purchase price for the transaction reported was $3.16, and the range of prices were between $3.15 and $3.19. Upon request from the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares purchased at each separate price will be provided.
  3. Includes 5 shares acquired under the issuer's Employee Stock Purchase Plan.